PRDX1 and cancer: Another outstanding question is how targeting PRDX1 or PRDX1-related antioxidant system would modify the response of cancer cells to transiently high (i.e., at mM ranges for Asc) concentrations achieved by intravenous application of either Asc or Men, and especially both compounds applied together.